Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

anti-B7-H4/MMAE ADC LNCB74

An antibody-drug conjugate (ADC) composed of a human immunoglobulin (Ig) G1 kappa monoclonal antibody directed against the T-cell checkpoint ligand B7-H4 (V-set domain-containing T-cell activation inhibitor 1; VTCN1; B7x; B7S1) conjugated, via a beta-glucuronidase-cleavable linker, to monomethyl auristatin E (MMAE), an auristatin derivative and a potent microtubule disrupting agent, with potential antineoplastic and immunomodulating activities. Upon administration of anti-B7-H4/MMAE ADC LNCB74, the anti-B7-H4 antibody targets and binds to B7-H4 expressed on tumor cells. Upon binding and internalization, MMAE is released upon cleavage by the cancer-associated lysosomal enzyme beta-glucuronidase. MMAE binds to tubulin and inhibits its polymerization, resulting in G2/M phase arrest and tumor cell apoptosis. This induces cell death in B7-H4-expressing cancer cells. LNCB74 also induces a bystander effect, thereby further killing neighboring tumor cells upon uptake of MMAE and induces an immune-mediated cell death. B7-H4, a member of the B7 family of immune modulators, is upregulated in a variety of tumor cell types and tumor-associated macrophages (TAMs) while minimally expressed in normal, healthy tissues. It negatively regulates T-cell immune responses. LNCB74 contains a LALA-hG1 Fc region to minimize uptake and toxicity to immune cells, thereby further improving the safety profile.
Synonym:ADC LNCB74
anti-B7-H4 ADC LNCB74
anti-B7-H4/MMAE antibody-drug conjugate LNCB74
antibody-drug conjugate LNCB74
Code name:LNCB 74
LNCB-74
LNCB74
Search NCI's Drug Dictionary